d-alpha tocopherol has been researched along with levetiracetam in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Doi, T; Nagatomo, K; Nakajima, A; Takaki, M; Ueda, Y; Willmore, LJ | 1 |
| Lerner, V; Miodownik, C | 1 |
| Aschermann, Z; Horváth, K; Komoly, S; Kovács, A; Kovács, N | 1 |
| Lerner, PP; Lerner, V; Miodownik, C | 1 |
| Bai, P; Chang, H; Chen, J; Feng, Y | 1 |
4 review(s) available for d-alpha tocopherol and levetiracetam
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Motor symptoms of schizophrenia: is tardive dyskinesia a symptom or side effect? A modern treatment.
Topics: Akathisia, Drug-Induced; Antipsychotic Agents; Fatty Acids, Omega-3; Ginkgo biloba; Humans; Levetiracetam; Melatonin; Movement Disorders; Neuroprotective Agents; Phytotherapy; Piracetam; Schizophrenia; Vitamin B 6; Vitamin E | 2011 |
[Treatment of tardive syndromes].
Topics: Amantadine; Antipsychotic Agents; Botulinum Toxins; Central Nervous System Agents; Cholinergic Antagonists; Clinical Trials as Topic; Clonazepam; Deep Brain Stimulation; Dopamine Antagonists; Ginkgo biloba; Humans; Levetiracetam; Movement Disorders; Nootropic Agents; Piracetam; Primary Prevention; Propranolol; Syndrome; Tetrabenazine; Vitamin E | 2014 |
Tardive dyskinesia (syndrome): Current concept and modern approaches to its management.
Topics: Adrenergic beta-Antagonists; Adrenergic Uptake Inhibitors; alpha-Tocopherol; Amantadine; Anticonvulsants; Antioxidants; Antipsychotic Agents; Clonazepam; Dopamine Agents; Drugs, Chinese Herbal; Fatty Acids, Omega-3; Ginkgo biloba; Humans; Isoleucine; Isoxazoles; Leucine; Levetiracetam; Melatonin; Movement Disorders; Nootropic Agents; Piracetam; Plant Extracts; Propranolol; Pyridoxine; Resveratrol; Stilbenes; Tetrabenazine; Valine; Vitamins; Zonisamide | 2015 |
3 other study(ies) available for d-alpha tocopherol and levetiracetam
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Levetiracetam enhances endogenous antioxidant in the hippocampus of rats: in vivo evaluation by brain microdialysis combined with ESR spectroscopy.
Topics: alpha-Tocopherol; Amino Acid Transport System y+; Amino Acid Transport Systems, Acidic; Amino Acids; Animals; Antioxidants; Ascorbic Acid; Blotting, Western; Electron Spin Resonance Spectroscopy; Hippocampus; Levetiracetam; Male; Microdialysis; Neuroprotective Agents; Nitric Oxide Synthase Type II; Nitrogen Oxides; Piracetam; Rats; Rats, Wistar | 2009 |
Diffuse posterior leukoencephalopathy in MELAS without stroke-like episodes: A case report.
Topics: Acidosis, Lactic; Ascorbic Acid; Female; Humans; Leukoencephalopathies; Levetiracetam; Male; MELAS Syndrome; Midazolam; Middle Aged; Stroke; Vitamin E; Vitamins | 2023 |